DRALZINE Drug Patent Profile
✉ Email this page to a colleague
When do Dralzine patents expire, and what generic alternatives are available?
Dralzine is a drug marketed by Teva and is included in one NDA.
The generic ingredient in DRALZINE is hydralazine hydrochloride. There are twenty-one drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dralzine
A generic version of DRALZINE was approved as hydralazine hydrochloride by STRIDES PHARMA on September 27th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DRALZINE?
- What are the global sales for DRALZINE?
- What is Average Wholesale Price for DRALZINE?
Summary for DRALZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Patent Applications: | 1,172 |
| DailyMed Link: | DRALZINE at DailyMed |
US Patents and Regulatory Information for DRALZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | DRALZINE | hydralazine hydrochloride | TABLET;ORAL | 084301-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
